Potassium Carbonate → HCID 58169453, compound
Reaction equation
C([N:4]1[C:8]([CH:9]2[CH2:11][CH2:10]2)=[CH:7][C:6]([NH:12][C:13]2[C:18]([C:19]#[CH:20])=[CH:17][N:16]=[C:15]([C:21]3[S:25][C:24]([S:26]([NH:29][C:30](=[O:32])[CH3:31])(=[O:28])=[O:27])=[CH:23][CH:22]=3)[N:14]=2)=[N:5]1)(=O)C.C([O-])([O-])=O.[K+].[K+]>CCO>[CH:9]1([C:8]2[NH:4][N:5]=[C:6]([NH:12][C:13]3[C:18]([C:19]#[CH:20])=[CH:17][N:16]=[C:15]([C:21]4[S:25][C:24]([S:26]([NH:29][C:30](=[O:32])[CH3:31])(=[O:27])=[O:28])=[CH:23][CH:22]=4)[N:14]=3)[CH:7]=2)[CH2:11][CH2:10]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The mixture of crude N-(5-(4-(1-acetyl-5-cyclopropyl-1H-pyrazol-3-ylamino)-5-ethynylpyrimidin-2-yl)thiophen-2-ylsulfonyl)acetamide and K2CO3 (43 mg, 0.31 mmol, 2.4 eq) in EtOH (10 mL) was stirred at room temperature for 1 h. The reaction mixture was filtered, the filtrate was concentrated. The residue was diluted with EtOAc and washed with water, brine, dried (Na2SO4), and filtered. The filtrate was concentrated and crystallized with ether to yield N-(5-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-ethynylpyrimidin-2-yl)thiophen-2-ylsulfonyl)acetamide (Compound 192) (65 mg, 84%). LC-MS (m/z)=429 [M+H]+; 1H NMR (400 MHz, DMSO-d6) δ 0.74-0.77 (m, 2H), 0.97-0.99 (m, 2H), 1.71 (s, 3H), 1.92-1.99 (m, 1H), 4.87 (s, 1H), 6.49 (s, 1H), 7.41 (d, J=4.0 Hz, 1H), 7.66 (d, J=3.6 Hz, 1H), 8.47 (s, 1H), 8.57 (bs, 1H), 12.31 (bs, 1H)
Workup
- filtrationThe reaction mixture was filtered
- concentrationthe filtrate was concentrated
- additionThe residue was diluted with EtOAc
- washwashed with water, brine
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationThe filtrate was concentrated
- customcrystallized with ether
Sources & evidence
- ORD record
- ord-5841390d82fc4595817ccb8972e1bc88
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09422271B2
Reaction notes
Loading…